Related Experiment Videos
The private costs of HIV/AIDS
R D Bowie1, M I Tobias, T Williams
1Department of Public Health, Wellington School of Medicine, Wellington.
The New Zealand Medical Journal
|February 23, 1996
Summary
The private costs of HIV/AIDS, including direct expenses and lost income, significantly increase as the illness progresses. These substantial financial burdens on individuals and families are often overlooked in broader economic analyses.
Area of Science:
- Medical Economics
- Public Health
- Social Sciences
Background:
- HIV/AIDS imposes significant financial burdens on individuals and their support networks.
- Previous economic analyses have often underestimated or excluded these private costs.
Purpose of the Study:
- To identify, measure, and value the private costs associated with HIV/AIDS.
- To understand the financial impact on people living with HIV/AIDS and their caregivers.
Main Methods:
- Prospective study of 25 individuals living with HIV in New Zealand.
- Inclusion of participants across different stages of the illness, from asymptomatic to AIDS.
- Comprehensive data collection on direct, indirect (foregone income), and intangible costs.
Main Results:
- Direct private costs escalate with disease progression, from approximately $100/month for asymptomatic individuals to $400/month for those with AIDS.
- Significant indirect costs, primarily from lost income, were observed.
- Considerable intangible costs, reflecting the non-financial impact of the illness, were also documented.
Conclusions:
- The private costs of HIV/AIDS, encompassing direct, indirect, and intangible factors, represent a substantial and burdensome aspect of the disease.
- Economic evaluations that omit these private costs provide an incomplete and potentially misleading picture of the true impact of HIV/AIDS.